US Stock MarketDetailed Quotes

LIPO Lipella Pharmaceuticals

Watchlist
  • 0.523
  • +0.016+3.14%
Trading Jul 11 13:18 ET
3.97MMarket Cap-706P/E (TTM)

Lipella Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lipella Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

145.88K

+23.58%
EPS(YoY)

-0.16

+15.79%
Analyst Rating

Buy

Jun 30, 2024

Lipella Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--------
--------
--------

Unlock Free Earnings Estimates

Lipella Pharmaceuticals Earnings Reports

  • Lipella Pharmaceuticals | 10-Q: Quarterly report

    May 9 16:14 ET

  • Lipella Pharmaceuticals | 10-K: Annual report

    Feb 27 16:58 ET

  • Lipella Pharmaceuticals: Q3 2023 Earnings Report

    Nov 14, 2023 06:14 ET

  • Lipella Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-3.57%